Overcoming Breast Cancer Resistance to CDK4/6 Inhibitors Through Genomic Discoveries
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have unveiled groundbreaking insights into the genetic interplay that fuels resistance to CDK4/6 inhibitors, a pivotal class...
















